Description
Rapidglim M2-Forte contains Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP. This combination is used to help manage blood glucose levels in adults with Type 2 Diabetes Mellitus when prescribed by a qualified healthcare professional.
Glimepiride helps the pancreas release insulin. Metformin helps reduce glucose production in the liver and improves the body’s response to insulin. Therefore, the two medicines work in different ways to support blood sugar control.
Brand Name: Rapidglim M2-Forte
Composition: Glimepiride + Metformin Hydrochloride Prolonged Release Tablets IP
Dosage Form: Prolonged Release Tablets
Therapeutic Category: Antidiabetic Medicine
Indication: Type 2 Diabetes Mellitus
Company: Rapid Life Drugs & Healthcare
Glimepiride + Metformin Hydrochloride Prolonged Release Tablets IP
Glimepiride + Metformin Hydrochloride Prolonged Release Tablets IP combine two antidiabetic medicines in one formulation. Doctors may prescribe this combination when diet, exercise or single-drug treatment does not provide enough blood glucose control.
Glimepiride belongs to the sulfonylurea class. It stimulates the pancreas to release insulin. On the other hand, Metformin belongs to the biguanide class. It reduces glucose production in the liver and helps the body respond better to insulin.
The prolonged-release formulation allows Metformin to release gradually. As a result, it supports extended action as part of the prescribed treatment plan.
Uses of Rapidglim M2-Forte
Doctors may prescribe Rapidglim M2-Forte to:
- Manage Type 2 Diabetes Mellitus
- Improve blood glucose control
- Support diabetes treatment along with diet and exercise
- Provide combination antidiabetic therapy
- Help patients who need more than one medicine for blood sugar management
However, this combination is not a standard treatment for Type 1 Diabetes Mellitus or diabetic ketoacidosis.
How Does Rapidglim M2-Forte Work?
Glimepiride
Glimepiride stimulates the pancreas to release insulin. The increased insulin helps the body lower elevated blood glucose levels.
Metformin Hydrochloride
Metformin reduces glucose production by the liver. It also improves insulin sensitivity. As a result, the body can use glucose more effectively.
Prolonged-Release Action
The prolonged-release form of Metformin releases the medicine gradually over time. Therefore, patients should take the tablet exactly as prescribed.
Do not crush or chew a prolonged-release tablet unless your doctor or the product instructions specifically allow it.
Benefits of Glimepiride + Metformin Tablets
Rapidglim M2-Forte provides two complementary actions for blood glucose management:
- Helps support better blood sugar control
- Combines Glimepiride and Metformin in one tablet
- Supports Type 2 Diabetes management
- Contains Metformin in prolonged-release form
- Can complement a healthy diet and regular physical activity
- Provides convenient combination therapy when prescribed
Dosage and Administration
Take Rapidglim M2-Forte only as prescribed by your doctor. The appropriate dose depends on your blood glucose levels, medical history, kidney function and response to treatment.
Take the tablet with water and follow the prescribed schedule. Do not change the dose or stop treatment without medical advice.
Since this is a prolonged-release formulation, swallow the tablet whole unless your doctor or the product leaflet gives different instructions.
Possible Side Effects
Some patients may experience side effects while taking Glimepiride and Metformin. These may include:
- Nausea
- Diarrhea
- Stomach discomfort
- Loss of appetite
- Headache
- Dizziness
- Low blood sugar
Side effects can vary between patients. Contact your doctor if any side effect becomes severe or continues for a long time.
Precautions
Before starting Rapidglim M2-Forte, tell your doctor about your medical history. Also, share details of all medicines and supplements you currently take.
Your doctor may need to monitor you carefully if you have:
- Kidney problems
- Liver problems
- A history of low blood sugar
- Excessive alcohol use
- Conditions that may cause dehydration
- A risk of vitamin B12 deficiency
Glimepiride can cause low blood sugar. Therefore, learn to recognize symptoms such as sweating, shaking, hunger, dizziness and confusion.
Metformin can rarely cause lactic acidosis. The risk can increase in people with severe kidney problems or certain other medical conditions.
Why Choose Rapidglim M2-Forte from Rapid Life Drugs & Healthcare?
Rapid Life Drugs & Healthcare offers pharmaceutical products across different therapeutic categories. Rapidglim M2-Forte – Glimepiride + Metformin Hydrochloride Prolonged Release Tablets IP is part of its antidiabetic product portfolio.
The combination brings together two different mechanisms to support blood glucose management in suitable patients with Type 2 Diabetes Mellitus.
For product information, availability and pharmaceutical business enquiries, contact Rapid Life Drugs & Healthcare.
Frequently Asked Questions
What is Rapidglim M2-Forte?
Rapidglim M2-Forte is a combination formulation containing Glimepiride + Metformin Hydrochloride Prolonged Release Tablets IP. Doctors may prescribe it to manage Type 2 Diabetes Mellitus.
What is the composition of Rapidglim M2-Forte?
Rapidglim M2-Forte contains Glimepiride and Metformin Hydrochloride in a prolonged-release formulation. Please confirm the exact strength from the approved product specification and packaging.
What is Glimepiride + Metformin used for?
Doctors use this combination to help control blood glucose levels in adults with Type 2 Diabetes Mellitus.
How does Glimepiride work?
Glimepiride stimulates the pancreas to release insulin. This helps lower elevated blood glucose levels.
How does Metformin work?
Metformin reduces glucose production by the liver. It also improves the body’s response to insulin.
Is Rapidglim M2-Forte a prescription medicine?
Yes. Use Rapidglim M2-Forte only under the guidance of a qualified healthcare professional.
Can Rapidglim M2-Forte be used for Type 1 Diabetes?
This combination is generally intended for Type 2 Diabetes Mellitus. It is not a standard treatment for Type 1 Diabetes.
About Rapid Life Drugs & Healthcare
Rapid Life Drugs & Healthcare is a pharmaceutical company offering products across different therapeutic segments. Its portfolio includes formulations for diabetes and other healthcare requirements.
The company offers Rapidglim M2-Forte – Glimepiride + Metformin Hydrochloride Prolonged Release Tablets IP as part of its antidiabetic product range.
For product enquiries and pharmaceutical business opportunities, contact Rapid Life Drugs & Healthcare.
